180 related articles for article (PubMed ID: 16487435)
1. Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians.
Rontu R; Ojala P; Hervonen A; Goebeler S; Karhunen PJ; Nikkilä M; Kunnas T; Jylhä M; Eklund C; Hurme M; Lehtimäki T
Clin Endocrinol (Oxf); 2006 Mar; 64(3):265-70. PubMed ID: 16487435
[TBL] [Abstract][Full Text] [Related]
2. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
3. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study.
Wong TY; Shankar A; Klein R; Bray MS; Couper DJ; Klein BE; Sharrett AR; Folsom AR
Ophthalmology; 2006 Feb; 113(2):255-9. PubMed ID: 16406547
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 modulates plasma cholesterol and C-reactive protein concentrations in nonagenarians.
Lehtimäki T; Ojala P; Rontu R; Goebeler S; Karhunen PJ; Jylhä M; Mattila K; Metso S; Jokela H; Nikkilä M; Wuolijoki E; Hervonen A; Hurme M
J Am Geriatr Soc; 2005 Sep; 53(9):1552-8. PubMed ID: 16137286
[TBL] [Abstract][Full Text] [Related]
6. Serum cholesterol, apolipoprotein E genotype and depressive symptoms in elderly European men: the FINE study.
Giltay EJ; van Reedt Dortland AK; Nissinen A; Giampaoli S; van Veen T; Zitman FG; Bots S; Kromhout D
J Affect Disord; 2009 Jun; 115(3):471-7. PubMed ID: 18990452
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E polymorphism in the Tunisian population: frequency and effect on lipid parameters.
Jemaa R; Elasmi M; Naouali C; Feki M; Kallel A; Souissi M; Sanhaji H; Hadj Taïeb S; Souheil O; Kaabachi N
Clin Biochem; 2006 Aug; 39(8):816-20. PubMed ID: 16714010
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E genotype affects the response to lipid-lowering therapy in Chinese patients with type 2 diabetes mellitus.
Tavintharan S; Lim SC; Chan YH; Sum CF
Diabetes Obes Metab; 2007 Jan; 9(1):81-6. PubMed ID: 17199722
[TBL] [Abstract][Full Text] [Related]
9. Gender-related effect of apo E polymorphism on lipoprotein particle sizes in the middle-aged subjects.
Topic A; Spasojevic Kalimanovska V; Zeljkovic A; Vekic J; Jelic Ivanovic Z
Clin Biochem; 2008 Apr; 41(6):361-7. PubMed ID: 18086568
[TBL] [Abstract][Full Text] [Related]
10. Obesity and alcohol modulate the effect of apolipoprotein E polymorphism on lipids and insulin.
Marques-Vidal P; Bongard V; Ruidavets JB; Fauvel J; Hanaire-Broutin H; Perret B; Ferrières J
Obes Res; 2003 Oct; 11(10):1200-6. PubMed ID: 14569045
[TBL] [Abstract][Full Text] [Related]
11. APOE-related mortality: effect of dementia, cardiovascular disease and gender.
Rosvall L; Rizzuto D; Wang HX; Winblad B; Graff C; Fratiglioni L
Neurobiol Aging; 2009 Oct; 30(10):1545-51. PubMed ID: 18237822
[TBL] [Abstract][Full Text] [Related]
12. Methodological problems in genetic association studies of longevity--the apolipoprotein E gene as an example.
Lewis SJ; Brunner EJ
Int J Epidemiol; 2004 Oct; 33(5):962-70. PubMed ID: 15319409
[TBL] [Abstract][Full Text] [Related]
13. The apolipoprotein E gene polymorphism is associated with open angle glaucoma in the Japanese population.
Mabuchi F; Tang S; Ando D; Yamakita M; Wang J; Kashiwagi K; Yamagata Z; Iijima H; Tsukahara S
Mol Vis; 2005 Aug; 11():609-12. PubMed ID: 16110302
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of apolipoprotein E and cognitive function in old age.
Mooijaart SP; van Vliet P; van Heemst D; Rensen PC; Berbée JF; Jolles J; de Craen AJ; Westendorp RG
Ann N Y Acad Sci; 2007 Apr; 1100():148-61. PubMed ID: 17460173
[TBL] [Abstract][Full Text] [Related]
15. Improvement of myocardial blood flow by lipid-lowering therapy with pravastatin is modulated by apolipoprotein E genotype.
Ilveskoski E; Lehtimäki T; Laaksonen R; Janatuinen T; Vesalainen R; Nuutila P; Laippala P; Karhunen PJ; Knuuti J
Scand J Clin Lab Invest; 2007; 67(7):723-34. PubMed ID: 17852827
[TBL] [Abstract][Full Text] [Related]
16. Presence of apolipoprotein E epsilon4 allele predisposes to early onset of primary Sjogren's syndrome.
Pertovaara M; Lehtimäki T; Rontu R; Antonen J; Pasternack A; Hurme M
Rheumatology (Oxford); 2004 Dec; 43(12):1484-7. PubMed ID: 15328426
[TBL] [Abstract][Full Text] [Related]
17. Lipid profile and apolipoprotein E polymorphism in essential hypertension.
Bhavani AB; Sastry KB; Reddy NK; Padma T
Indian Heart J; 2005; 57(2):151-7. PubMed ID: 16013355
[TBL] [Abstract][Full Text] [Related]
18. APOE genotype and serum cholesterol in predicting risk for early death from ischemic stroke in men and women.
Gromadzka G; Barańska-Gieruszczak M; Ciesielska A; Sarzyńska-Dlugosz I; Członkowska A
Cerebrovasc Dis; 2005; 20(5):291-8. PubMed ID: 16131797
[TBL] [Abstract][Full Text] [Related]
19. Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein.
Chasman DI; Kozlowski P; Zee RY; Kwiatkowski DJ; Ridker PM
Genes Immun; 2006 Apr; 7(3):211-9. PubMed ID: 16511556
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of plasma high sensitive C-reactive protein in detecting three-vessel coronary artery disease: modification by apolipoprotein E genotype.
Mennander A; Kuukasjärvi P; Laurikka J; Nikus K; Karhunen PJ; Tarkka M; Lehtimäki T
Scand J Clin Lab Invest; 2008; 68(8):714-9. PubMed ID: 18609102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
